mRNA主要增强疫苗接种促进了生殖中心反应中的克隆连续性,并扩大了SARS-CoV-2变种覆盖范围
Matias Ciancaglini1, Jonas Fixemer1, Cemre Seven1
1Department of Biomedicine, University of Basel, Petersplatz 10, 4051 Basel, Switzerland.
概括
与腺病毒/mRNA相比,mRNA/mRNA接种促进了持久的B细胞反应和更广泛的抗体保护对抗SARS-CoV-2变体. 高B细胞克隆连续性是针对不断演变的病原体的有效疫苗的关键.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 在SARS-CoV-2疫苗中,mRNA和腺病毒 (rAd) 平台在主要提升策略中使用.
- 不同疫苗方案对B细胞克隆连续性的影响尚不清楚.
研究的目的:
- 为了研究 SARS-CoV-2 特定的 B 细胞动力学和克隆连续性,在接种不同主要增强方案的小鼠中进行.
- 为了比较mRNA/mRNA,rAd/mRNA和rAd/rAd主要提升策略的有效性.
主要方法:
- 在接种疫苗的小鼠中描述SARS-CoV-2特定的生殖中心 (GC) B细胞动态.
- 进行B细胞命运测绘实验以追踪克隆连续性.
- 测量中和抗体 (nAb) 标位和变体覆盖范围.
主要成果:
- mRNA/mRNA和rAd/mRNA的原始提升诱导了相当的nAb标位,但mRNA/mRNA提供了更广泛的变异覆盖范围.
- mRNA/mRNA在初级和二级GC反应之间显示出更高的B细胞克隆连续性.
- 同源rAd/rAd疫苗接种导致向量脊柱偏差抗体和有限的SARS-CoV-2特异性B细胞克隆连续性.
结论:
- mRNA/mRNA原始增强增强B细胞克隆连续性和持久的GC反应,从而对SARS-CoV-2变体进行更广泛的保护.
- 高B细胞克隆连续性对于开发针对SARS-CoV-2等快速演变的病原体的有效疫苗接种策略至关重要.
关键词:
这就是SARS-CoV-2病毒.腺病毒载体病毒载体.克隆性选择 克隆性选择发芽中心是生殖中心.在mRNA疫苗的使用中.中和抗体中和抗体.主要增强免疫接种的免疫.接种疫苗 接种疫苗变体覆盖范围的变体覆盖范围更多相关视频
相关概念视频
Vaccinations
45.3K
Overview
45.3K
Cells of the Adaptive Immune Response
4.1K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
4.1K
T Cell Activation and Clonal Selection
4.6K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
4.6K
Immunological Memory
4.9K
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
4.9K
Antigens Involved in Adaptive Immunity
669
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
669
Cancer Vaccines
509
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509


